Metamucil Fibre Therapy Capsules
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Caramel, FD&C Yellow 6 lake, Poly(sorbate) 80, Gélatine, FD&C Red 40 aluminium lake, FD&C Blue #1
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 13 years | 5 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Adultes | Not specified | 5 Capsule | 4 Tous les jours |
| Adultes | Not specified | 5 Capsule | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Gentle relief of irregularity. Metamucil promotes, restores, and maintains regularity. Dietary Fibre Supplement. Promotes digestive health (or digestive wellness) by relieving irregularity). Cholesterol-Lowering agent*/Lowers cholesterol levels*. *Lowers (mildly to moderately) elevated cholesterol levels (when taken) with a low fat diet. Promotes heart health. Soluble fibre from psyllium, when included as part of a diet low in saturated fat and cholesterol, may reduce risk of (coronary) heart disease by lowering cholesterol levels. Helps to maintain a healthy cardiovascular system by (promoting healthy cholesterol levels) or (lowering cholesterol levels). Helps support healthy blood sugar levels. It helps your body maintain healthy blood sugar levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Product record
- Other names
- Meta Daily Blood Sugar Support, Metamucil Fibre Therapy 3 in 1, Metamucil Fibre Therapy 3 in 1 Fibre Capsules
- Licence holder
- Procter & Gamble Inc.
- NPN or DIN-HM
- 02247034
- Status
- Active licence
- Licence date
- 25 March 2008
- Revision date
- 1 February 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
Source
Official Health Canada record, licence 02247034
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.